Emerging biomarkers in thyroid practice and research

S Agarwal, A Bychkov, CK Jung - Cancers, 2021 - mdpi.com
Simple Summary Tumor biomarkers are molecules at genetic or protein level, or certain
evaluable characteristics. These help in perfecting patient management. Over the past …

Immunohistochemistry helps to distinguish noninvasive follicular thyroid neoplasm with papillary-like nuclear features/noninvasive encapsulated follicular variant of …

HW Chuang, JS Wang, JW Tsai, CT Hsu, KJ Lin - Medicina, 2021 - mdpi.com
Background and Objectives: We aimed to assess the diagnostic value of various
immunohistochemical (IHC) markers and panels for differentiation among benign follicular …

[HTML][HTML] Challenge in the pathological diagnosis of the follicular-patterned thyroid lesions

DA Elsers, MRA Hussein, MH Osman… - Asian Pacific journal …, 2021 - ncbi.nlm.nih.gov
Background: The follicular-patterned thyroid lesions (FPTLs) include hyperplastic nodules
(HN), follicular adenoma (FA), non-invasive follicular neoplasm with papillary-like nuclear …

Utility of Immunohistochemistry Markers CK19, Gal-3, HBME-1 and Their Combinations for Differential Diagnosis of Thyroid Diseases

A Dağlar Aday, H Demir, T Öztürk - Indian Journal of Surgery, 2023 - Springer
Differential diagnosis is important for clinical management of cases with thyroid diseases.
We aimed to find the most useful diagnostic panel including immunohistochemistry markers …

Diagnostic utility of CK19 and galectin-3 in differentiating papillary thyroid carcinoma from nonneoplastic lesions of thyroid

PA Prasad, K Raju - Journal of Cancer Research and …, 2022 - journals.lww.com
Background: Thyroid neoplasm is one of the most common endocrine neoplasms. The
diagnosis and the distinction between malignant and benign neoplasms can be difficult, but …

Diagnostic role of immunohistochemical markers CK19 and CD56 in thyroid neoplasms

P Priyadarshini, MK Patro, PK Das - MGM Journal of Medical …, 2023 - journals.lww.com
Materials and Methods: Total/hemithyroidectomy specimens received in the Department of
Pathology, Maharaja Krushna Chandra Gajapati Medical College and Hospital, Brahmapur …

The diagnostic utility of INSM1 and GATA3 in discriminating problematic medullary thyroid carcinoma, thyroid and parathyroid lesions

SA Hakim, NM Abd Raboh - Polish Journal of Pathology, 2021 - termedia.pl
Discriminating thyroid and parathyroid lesions may sometimes pose a diagnostic difficulty.
Medullary thyroid carcinomas (MTCs) display various cytologic and architectural features …

[HTML][HTML] BRAF V600E, p53, CD56, CK19, Galectin-3, TPO 在247 例甲状腺乳头状癌的表达与诊断价值

胡诗梦, 王敏 - Advances in Clinical Medicine, 2022 - hanspub.org
目的: 探讨甲状腺乳头状癌(papillary thyroid carcinoma, PTC) 的BRAF V600E, p53, CD56,
CK19, Galectin-3, TPO 的表达及诊断价值. 方法: 选取2019 年12 月至2021 年12 …

Application of immunohistochemistry in papillary thyroid carcinoma

AK Lam, KTW Lee - Papillary Thyroid Carcinoma, 2022 - Springer
Immunohistochemistry (IHC) is an economic and precise method to localize the presence of
specific protein at cellular level in tissue. Although many papillary thyroid carcinomas do not …

Expression of CD10 and CD56 in Benign and Malignant Thyroid Lesions

SA MAHMOUD, AG HUSSIEN… - The Medical Journal of …, 2022 - journals.ekb.eg
Background: CD 10 was initially recognised as a cell–sur-face antigen expressed by acute
lymphoblastic leukaemias, and hence it's early designation as Common Acute Lymphob …